Friday 6^th November 2015

Multiple Myeloma

13:45      Welcome and Introduction (D. Betticher, Fribourg/M. Ghielmini, Bellinzona)

14:00      Laboratory tests and new diagnostic criteria in MM (L. Bernasconi, Aarau)

14:30      Is there a best triplet for first line treatment? (U. Hess, St Gallen)

15:00      Consolidation and/or maintenance after HDCT (H. Goldschmidt, Heidelberg)

15:30      Discussion of 3 challenging clinical cases (complications of myeloma)

16:00      Coffee break

16:30      Treatment algorithm(s) for non-transplantable patients (C. Taverna, Münsterlingen)

17:00      New drugs for relapsed/refractory MM (C. Driessen, St Gallen)

17:30      Amyloidosis (B. Gerber, Zürich)

18:00      Discussion of 3 challenging clinical cases (management of relapses)                

18:30      Adjourn

Saturday 7^th November 2015

CLL

08:00      Differential diagnosis of monoclonal lymphocytosis (A. Tichelli, Basel)

08:30      Which is the best anti-CD20 for CLL? (M. Gregor, Luzern)

09:00      Fludarabine, bendamustine or chlorambucil? (C.M. Wendtner, München)

09:30      Discussion of 3 challenging clinical cases (complications of CLL)

10:00      Coffee break

10:30      Allogeneic transplantation: when and how (D. Heim, Basel)

11:00      New drugs for CLL (P. Ghia, Milano)

11:30      Richter’s transformation (D. Rossi, Novara)

12:00      Discussion of 3 challenging clinical cases (management of relapses)

12:30      End